Heterocyclyl-butanamide derivatives

A compound of formula I

• in which
• W denotes
• wherein * indicates the point of attachment to the propylene moiety,
• X denotes O, CO or is absent,
• Y denotes Ar or Het1,
• R1 denotes H, F, Cl, CN, CH3, CF3, CHF2, CH2OH or OCH3,
• R2 denotes H or CH3,
• Ar denotes phenyl, which is unsubstituted, or mono-, di- or trisubstituted by Hal, NO2, CN, A, OR3, S(O)mR3, N(R3)2, COA, COOR3, CON(R3)2, SO2N(R3)2, NR3COR3, NR3SO2A, NR3CON(R3)2 and/or Het2,
• Het1 denotes furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, triazolyl, tetrazolyl, pyridyl, pyrimidyl or pyridazinyl, each of which is unsubstituted or mono- or disubstituted by Hal, NO2, Ar1, CN, A, OR3, N(R3)2, CON(R3)2, Het2 and/or ═O,
• Het2 denotes furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, triazolyl, tetrazolyl, pyridyl, pyrimidyl or pyridazinyl, each of which is unsubstituted or mono- or disubstituted by Hal, NO2, Ar1, CN, A, OR3, N(R3)2, CON(R3)2 and/or ═O,
• Ar1 denotes phenyl, which is unsubstituted, or mono-, di- or trisubstituted by Hal, NO2, CN, A, OR3, S(O)mR3, N(R3)2, COA, COOR3, CON(R3)2, NR3COR3 and/or NR3SO2A,
• A denotes unbranched or branched alkyl with 1-8 C-Atoms, wherein one or two non-adjacent CH- and/or CH2-groups may each be replaced by N- or O-atoms and wherein 1-7 H-atoms may each be replaced by F, Cl or OH,
• R3 denotes H or unbranched or branched alkyl with 1, 2, 3 or 4 C-Atoms,
• Hal denotes F, Cl, Br or I,
• m denotes 0, 1 or 2,
• n denotes 1 or 2,
• and pharmaceutically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.